1. Fragility of sub-cellular structures in chronic lymphocytic leukemia

   • Ben-Zion Katz
   • Yair Herishanu

   Images in Hematology 21 March 2017 Pages: 707 - 708

   

2. Guest Editorial: Understanding of MPN and MDS/MPN based on molecular pathogenesis and clinical aspects

   • Hironori Harada

   Progress in Hematology 26 April 2017 Pages: 709 - 710

3. CMML: Clinical and molecular aspects

   • Raphael Itzykson
   • Matthieu Duchmann
   • Eric Solary

   Progress in Hematology 28 April 2017 Pages: 711 - 719

   

4. Splicing factor mutations in MDS RARS and MDS/MPN-RS-T

   • Akihide Yoshimi
   • Omar Abdel-Wahab

   Progress in Hematology 02 May 2017 Pages: 720 - 731

   

5. Somatic SETBP1 mutations in myeloid neoplasms

   • Hideki Makishima

   Progress in Hematology 26 April 2017 Pages: 732 - 742

   

6. Somatic mutations of calreticulin in myeloproliferative neoplasms

   • Misa Imai
   • Marito Araki
   • Norio Komatsu

   Progress in Hematology 03 May 2017 Pages: 743 - 747

   

7. Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19⁺ B lymphocytes in the peripheral blood

   • Jeffrey D. McBride
   • Xiaochen Liu
   • Jian-xing Ma

   Original Article 15 March 2017 Pages: 748 - 757

   

8. The fibrous form of intracellular inclusion bodies in recombinant variant fibrinogen-producing cells is specific to the hepatic fibrinogen storage disease-inducible variant fibrinogen

   • Shinpei Arai
   • Naoko Ogiwara
   • Nobuo Okumura

   Original Article 04 February 2017 Pages: 758 - 768

   

9. Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience

   • Alfredo Molteni
   • Marta Riva
   • Roberto Cairoli

   Original Article 20 February 2017 Pages: 769 - 776

   

10. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome

    • Jing Wen
    • Ying Huang
    • Zhenfang Liu

    Original Article 21 February 2017 Pages: 777 - 783

    

11. Detection of minimal residual disease in childhood B-acute lymphoblastic leukemia by 4-color flowcytometry

    • Ahmad Baraka
    • Laila M. Sherief
    • Shereen El Shorbagy

    Original Article 21 March 2017 Pages: 784 - 791

    

12. Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report

    • Hirohisa Nakamae
    • Shin Fujisawa
    • Masafumi Miyoshi

    Original Article 24 March 2017 Pages: 792 - 804

    

13. Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation

    • Akio Shigematsu
    • Shinichi Kako
    • Junji Tanaka

    Original Article 14 February 2017 Pages: 805 - 811

    

14. Predictors of vasovagal reactions during preoperative autologous blood donation: a single-institution analysis

    • Hisakazu Nishimori
    • Nobuharu Fujii
    • Kazuma Ikeda

    Original Article 07 March 2017 Pages: 812 - 818

    

15. The first validated criteria for effective screening and a new simplified method for α-globin gene sequencing for diagnosis of uncommon α-globin mutations

    • Noppacharn Uaprasert
    • Rung Settapiboon
    • Ponlapat Rojnuckarin

    Original Article 06 February 2017 Pages: 819 - 827

    

16. Application of an improved flow cytometry-based NK cell activity assay in adult hemophagocytic lymphohistiocytosis

    • Jia Zhang
    • Yini Wang
    • Zhao Wang

    Original Article 09 February 2017 Pages: 828 - 834

    

17. Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia

    • Ryoko Yamasaki
    • Junya Kanda
    • Yoshinobu Kanda

    Original Article 06 February 2017 Pages: 835 - 840

    

18. Bleeding tendency and platelet function during treatment with romiplostim in children with severe immune thrombocytopenic purpura

    • Elena V. Suntsova
    • Irina M. Demina
    • Mikhail A. Panteleev

    Original Article 07 March 2017 Pages: 841 - 848

    

19. Pediatric follicular lymphoma in Japan

    • Ryoji Kobayashi
    • Fumiko Tanaka
    • Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group

    Original Article 07 March 2017 Pages: 849 - 853

20. Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56− chronic lymphoproliferative disorder of NK-cells

    • Nodoka Sekiguchi
    • Sayaka Nishina
    • Fumihiro Ishida

    Case Report 27 December 2016 Pages: 854 - 858

    

21. Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion

    • Eric Oksenhendler
    • Jocelyn Turpin
    • Antoine Gessain

    Case Report 30 January 2017 Pages: 859 - 862